B.JazetI
Post-grad school, she worked as a freelance writer and as The Daily Beasts first Beauty, Health, and Wellness Reporter
"DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case-Control Study"
Yuhan Corporation has adopted a unique approach in the obesity treatment market, deviating from the mainstream use of GLP-1
Further research is warranted to elucidate underlying mechanisms and optimize patient selection
The Harsh Reality of GLP-1 Injections Initially, GLP-1 injections seemed promising, but the adverse effects quickly became apparent: Immediate side effects: Severe nausea, diarrhea, constipation Long-term risks: Increased chance of pancreatitis, thyroid issues, gallbladder diseases Financial burden: High cost with inevitable weight regain upon discontinuation Determined to find a safer, lasting solution, I turned to natural microbiome-focused therapies